← Back to patent-cliff list
AB-2004
Tier C — Watch / tradeAB-2004
California Institute Of Technology
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：自闭症谱系障碍
Regional status
US
Phase II
2021-08-02
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of AB-2004?
Approved indications include: 自闭症谱系障碍.
When does the AB-2004 patent expire?
No public expiry year is available for AB-2004 yet; this page updates once verified.
How do I get a quote for AB-2004 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06